News

June 3, 2020June 3, 2020

FDA Approves Tecentriq-Avastin Combo for Newly Diagnosed Advanced Liver Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) for the treatment of newly diagnosed patients with advanced hepatocellular carcinoma (HCC), the ... Read more

June 1, 2020June 1, 2020

Surface, Merck Partner on SRF617-Keytruda Combo Targeting Solid Tumors

News

Surface Oncology has entered a collaboration with Merck to investigate a combination of SRF617 and Keytruda (pembrolizumab) in patients with solid tumors, with a particular focus on individuals with ... Read more

May 26, 2020May 26, 2020

ONCOS-102 Plus Chemo Showing Sustained Benefit in Mesothelioma Trial

News

A combination of ONCOS-102 plus standard chemotherapy continues to extend the time without disease progression and appears to induce immune system activity in people with malignant pleural mesothelioma unable ... Read more

May 20, 2020May 20, 2020

FDA Approves Tecentriq as Initial Treatment for Advanced NSCLC

News

The U.S. Food and Drug Administration (FDA) has approved Genentech‘s Tecentriq (atezolizumab) as an initial treatment of people with metastatic non-small cell lung cancer (NSCLC) whose tumors produce high levels of ... Read more

May 19, 2020May 19, 2020

FDA Approves Opdivo-Yervoy Combo for First-line Treatment of Advanced NSCLC

News

The U.S. Food and Drug Administration (FDA) has approved a combination of Opdivo (nivolumab) with low-dose Yervoy (ipilimumab) for the initial treatment of people with metastatic non-small cell lung ... Read more

May 12, 2020May 12, 2020

ICT’s CAR T-cell Therapy Shows Promise in Reducing Size of Solid Tumors

News

A potential CAR T-cell therapy by Innovative Cellular Therapeutics (ICT) showed early signs of safety and efficacy, significantly reducing tumor size in four patients with thyroid or colorectal cancer, new ... Read more

May 5, 2020May 5, 2020

Dostarlimab Shows Promise for Advanced Endometrial Cancer, Early Trial Results Show

News

A subset of women with recurrent or advanced endometrial cancer, whose disease progressed on or after platinum-based chemotherapy, achieved clinically meaningful responses after treatment with dostarlimab, results of a ... Read more

April 28, 2020April 28, 2020

Study: Opdivo-Cabometyx Combo Extends Survival, Increases Response Rates in Advanced Kidney Cancer

News

Combining Cabometyx (cabozantinib) with Opdivo (nivolumab) significantly extends survival, delays disease progression and increases the rate of positive responses compared to standard treatment with Sutent (sunitinib) among people with newly diagnosed ... Read more

April 27, 2020April 27, 2020

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

News, syndicated

While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands, hobbled economies worldwide and drove millions to quarantine in ... Read more

April 21, 2020April 21, 2020

Bavencio Seen as Ineffective in Phase 3 Head and Neck Cancer Trial

News

A Phase 3 trial of Bavencio (avelumab) in people with squamous cell carcinoma of the head and neck (SCCHN) was ended early due to a lack of effectiveness seen ... Read more

Pin It on Pinterest